 
		
					Valeritas Reports Record Second Quarter Revenue with 36% Year-over-Year Growth
Company’s Fourth Consecutive Quarter of Record Revenue and Third Consecutive Quarter with Year-Over-Year Revenue Growth Exceeding 20% […]
 
		
					Company’s Fourth Consecutive Quarter of Record Revenue and Third Consecutive Quarter with Year-Over-Year Revenue Growth Exceeding 20% […]
 
		
					During the interview Mr. Rossi discussed FNHI’s business model and their main subsidiary Worksport, which focuses on the tonneau/truck bed cover market. […]
 
		
					“We are delighted to announce patients with type 2 diabetes in New Zealand now have access to V-Go® Wearable Insulin Delivery device,” said Valeritas CEO, John Timberlake. […]
 
		
					NEW YORK, July 10, 2018 (GLOBE NEWSWIRE) — The Wall Street Analyzer recently conducted an interview with Generation Next Franchise Brands’ (OTC:VEND) Chairman Nick Yates, and their CEO Art Budman. […]
 
		
					The Franchise Company Also Completes its Fourth Quarter of Fiscal 2018 with Robust Bookings of 240 Robots Aggregating Over $10 Million SAN DIEGO, CA, July 09, 2018 (GLOBE NEWSWIRE) — Generation NEXT Franchise Brands (OTCQB: […]
 
		
					RICHMOND, Va., July 02, 2018 (GLOBE NEWSWIRE) — Synalloy Corporation (Nasdaq:SYNL) today announced that its subsidiary Bristol Metals, LLC has closed on the purchase of Marcegaglia USA’s galvanized tube operations. The purchase price for the […]
 
		
					(TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) […]
 
		
					RICHMOND, Va., June 11, 2018 (GLOBE NEWSWIRE) — Synalloy Corporation (Nasdaq:SYNL) is set to join the broad-market Russell 3000 Index at the conclusion of the Russell US indexes annual reconstitution, effective after the U.S. market […]
 
		
					TORONTO, May 24, 2018 (GLOBE NEWSWIRE) — Victoria Gold Corp. (TSX-V:VIT) “Victoria” or the “Company” is pleased to provide a construction update for the Eagle Gold Mine Project (the “Project”), Yukon Canada. Full construction commenced […]
 
		
					NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) — Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ:VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, took time to update WSA’s investor […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com